Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 PC (procarbazine + CCNU) chemotherapy in recurrent or resistant glioblastoma with methylated MGMT
KCT0000605Phase 2Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2012
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of procarbazine, lomustine in glioblastoma (GBM), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Oct 2012; status: recruiting.
02
Drugs
procarbazinelomustine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on KCT0000605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000605.